Article
β-Arrestins and disease-linked variants: opportunities for targeted modulation.
Trends in pharmacological sciences - 1 Mar 2026
Hasinger Simon, Fraunhofer Andreas, Hermes Julius, McCormick Peter J, Gruber Christian W
Abstract excerpt
G protein-coupled receptors orchestrate numerous physiological processes and represent the largest class of drug targets, yet their intracellular regulators, the β-arrestins, remain largely underexplored. Despite their crucial roles in receptor desensitization, trafficking, and signaling, few modulators have been identified, with limited isoform selectivity. Therapeutic efforts have mainly focused on...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
